When patients struggle to see a positive path forward, modeling a constructive journey can give them the confidence they need.
Matthew Froestad, SVP, Client Services, Snow Companies
Advertisement
During his decade-long tenure at SNOW, Matthew Froestad has gathered insights into a wide cross-section of the life science industry and become a resource for anyone interested to know more about the oncology landscape. He can be reached at [email protected]
Articles by Matthew Froestad, SVP, Client Services, Snow Companies
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Mark Cuban Confirms Cost Plus Drugs Partnership
2
Why Rising Complexity and R&D Costs Are Fueling Specialty Drug Spending
3
BioNTech Launches Public Exchange Offer for CureVac in $1.25B All-Stock Deal
4
Pharma Pulse: MJH Life Sciences Expands into Health Systems, Novo Nordisk Board Shakeup Moves Markets, and Mark Cuban Grows Cost Plus Drugs Network
5
